Acta pharmacologica Sinica, 2019-07, Vol.40 (7), p.980-988
2019
Details
- Autor(en) / Beteiligte
- Titel
- Metabolism and disposition of pyrotinib in healthy male volunteers: covalent binding with human plasma protein
- Ist Teil von
- Acta pharmacologica Sinica, 2019-07, Vol.40 (7), p.980-988
- Ort / Verlag
- United States: Nature Publishing Group
- Erscheinungsjahr
- 2019
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Pyrotinib is a novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor that is used to treat HER2-positive breast cancer. In this study we investigated the metabolism and disposition of pyrotinib in six healthy Chinese men after a single oral dose of 402 mg of [ C]pyrotinib. At 240 h postdose, the mean cumulative excretion of the dose radioactivity was 92.6%, including 1.7% in urine and 90.9% in feces. In feces, oxidative metabolites were detected as major drug-related materials and the primary metabolic pathways were O-depicoline (M1), oxidation of pyrrolidine (M5), and oxidation of pyridine (M6-1, M6-2, M6-3, and M6-4). In plasma, the major circulating entities identified were pyrotinib, SHR150980 (M1), SHR151468 (M2), and SHR151136 (M5), accounting for 10.9%, 1.9%, 1.0%, and 3.0%, respectively, of the total plasma radioactivity based on the AUC ratios. Approximately 58.3% of the total plasma radioactivity AUC was attributed to covalently bound materials. After incubation of human plasma with [ C]pyrotinib at 37 °C for 2, 5, 8, and 24 h, the recovery of radioactivity by extraction was 97.4%, 91.8%, 69.6%, and 46.7%, respectively, revealing covalent binding occurred independently of enzymes. A group of pyrotinib adducts, including pyrotinib-lysine and pyrotinib adducts of the peptides Gly-Lys, Lys-Ala, Gly-Lys-Ala, and Lys-Ala-Ser, was identified after HCl hydrolysis of the incubated plasma. Therefore, the amino acid residue Lys190 of human serum albumin was proposed to covalently bind to pyrotinib via Michael addition. Finally, the covalently bound pyrotinib could dissociate from the human plasma protein and be metabolized by oxidation and excreted via feces.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1671-4083eISSN: 1745-7254DOI: 10.1038/s41401-018-0176-6Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6786348
- Format
- –
- Schlagworte
- Acrylamides - chemistry, Acrylamides - metabolism, Acrylamides - pharmacokinetics, Adducts, Adult, Amino acids, Aminoquinolines - chemistry, Aminoquinolines - metabolism, Aminoquinolines - pharmacokinetics, Antineoplastic Agents - chemistry, Antineoplastic Agents - metabolism, Antineoplastic Agents - pharmacokinetics, Blood Chemical Analysis, Blood plasma, Breast cancer, Carbon Radioisotopes, Covalence, Enzyme inhibitors, Epidermal growth factor receptors, ErbB-2 protein, Excretion, Feces, Feces - chemistry, Human serum albumin, Humans, Lysine, Male, Metabolic pathways, Metabolism, Metabolites, Orosomucoid - metabolism, Oxidation, Peptides, Plasma, Protein Binding, Protein Kinase Inhibitors - chemistry, Protein Kinase Inhibitors - metabolism, Protein Kinase Inhibitors - pharmacokinetics, Protein-tyrosine kinase, Pyridines, Pyrrolidine, Radioactivity, Serum Albumin, Human - chemistry, Serum Albumin, Human - metabolism, Urine, Urine - chemistry